Abstract: The present invention relates to solid state forms of Gonadotropin-Releasing Hormone Receptor (GnRH) antagonist of Formula (I) and a pharmaceutically acceptable salt thereof, namely 1-(4-(l-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxy pyridazin-3-yl -2,4-dioxo-l,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea, and its pharmaceutically acceptable salts thereof, methods of their preparation, pharmaceutical compositions thereof and methods of their use.
| # | Name | Date |
|---|---|---|
| 1 | 202417015021-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [29-02-2024(online)].pdf | 2024-02-29 |
| 2 | 202417015021-STATEMENT OF UNDERTAKING (FORM 3) [29-02-2024(online)].pdf | 2024-02-29 |
| 3 | 202417015021-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [29-02-2024(online)].pdf | 2024-02-29 |
| 4 | 202417015021-FORM 1 [29-02-2024(online)].pdf | 2024-02-29 |
| 5 | 202417015021-DRAWINGS [29-02-2024(online)].pdf | 2024-02-29 |
| 6 | 202417015021-DECLARATION OF INVENTORSHIP (FORM 5) [29-02-2024(online)].pdf | 2024-02-29 |
| 7 | 202417015021-COMPLETE SPECIFICATION [29-02-2024(online)].pdf | 2024-02-29 |
| 8 | 202417015021-Proof of Right [30-04-2024(online)].pdf | 2024-04-30 |
| 9 | 202417015021-FORM-26 [30-04-2024(online)].pdf | 2024-04-30 |
| 10 | 202417015021-FORM 3 [29-08-2024(online)].pdf | 2024-08-29 |
| 11 | 202417015021-FORM 18 [12-09-2025(online)].pdf | 2025-09-12 |